This inventor holds 2 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignees: Glaxosmithkline Intellectual Property Development Limited, Nanyang Technological University, National University of Singapore. Active years: 2020-2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 242 
1 out of 685 
1 out of 857 
Years Active: 2020-2021
Title: Kevin Pethe: Innovator in Antituberculosis Research
Introduction
Kevin Pethe is a notable inventor based in Singapore, SG. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds for treating tuberculosis. With a total of 2 patents, his work is focused on innovative solutions to combat this serious health issue.
Latest Patents
Kevin Pethe's latest patents include groundbreaking inventions aimed at treating tuberculosis. One of his patents involves pyrimidine compounds and compositions that target the F-domain of F-ATP synthase. These compounds can be used in conjunction with existing treatments such as bedaquiline or Q203. Another significant patent pertains to an antituberculosis agent, which relates to the use of 6-((4-(2,3-dimethylphenoxy)piperidin-1-yl)methyl)pyrimidine-2,4(1H,3H)-dione and its pharmaceutically acceptable salts. This invention also includes pharmaceutical formulations that utilize these compounds.
Career Highlights
Throughout his career, Kevin Pethe has worked with esteemed organizations such as the National University of Singapore and GlaxoSmithKline Intellectual Property Development Limited. His experience in these institutions has allowed him to advance his research and contribute to the development of effective treatments for tuberculosis.
Collaborations
Kevin has collaborated with notable professionals in his field, including Robert H. Bates and Gerhard Grüber. These partnerships have enhanced his research efforts and have been instrumental in the success of his inventions.
Conclusion
Kevin Pethe is a dedicated inventor whose work in antituberculosis research has the potential to make a significant impact on public health. His innovative patents and collaborations reflect his commitment to finding effective solutions for treating this disease.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile